Difference between revisions of "Apligraf"
Jump to navigation
Jump to search
m (Fixed date format error.) |
m (add interlanguage link) |
||
| Line 1: | Line 1: | ||
<!-- [[Image:Alloderm-logo.jpg|right|thumb|]] --> | <!-- [[Image:Alloderm-logo.jpg|right|thumb|]] --> | ||
Apligraf is a synthetic skin created from harvested foreskins.<ref>{{REFweb | Apligraf is a synthetic skin created from harvested foreskins.<ref>{{REFweb | ||
| − | | quote=Human keratinocytes and fibroblasts are derived from neonatal foreskins | + | |quote=Human keratinocytes and fibroblasts are derived from neonatal foreskins |
| − | | url=http://www.apligraf.com/professional/what_is_apligraf/how_is_it_made/ | + | |url=http://www.apligraf.com/professional/what_is_apligraf/how_is_it_made/ |
| − | | title=Apligraf: How Is It Made? | + | |title=Apligraf: How Is It Made? |
| − | | last= | + | |last= |
| − | | first= | + | |first= |
| − | | publisher=Organogenesis | + | |publisher=Organogenesis |
| − | | date= | + | |date= |
| − | | accessdate=2011-03-06 | + | |accessdate=2011-03-06 |
}}</ref> It is [[FDA]] approved,<ref>{{REFweb | }}</ref> It is [[FDA]] approved,<ref>{{REFweb | ||
| − | | quote=Apligraf® is the first bio-engineered cell based product to receive FDA approval (in 1998). | + | |quote=Apligraf® is the first bio-engineered cell based product to receive FDA approval (in 1998). |
| − | | url=http://www.organogenesis.com/products/bioactive_woundhealing/apligraf.html | + | |url=http://www.organogenesis.com/products/bioactive_woundhealing/apligraf.html |
| − | | title=Apligraf | + | |title=Apligraf |
| − | | last= | + | |last= |
| − | | first= | + | |first= |
| − | | publisher=Organogenesis | + | |publisher=Organogenesis |
| − | | date= | + | |date= |
| − | | accessdate=2011-03-06 | + | |accessdate=2011-03-06 |
}}</ref> and it is made and sold by [[Organogenesis]], which a corporation based in Canton, MA. Novartis Pharmaceuticals Corp. has global marketing rights to Apligraf. | }}</ref> and it is made and sold by [[Organogenesis]], which a corporation based in Canton, MA. Novartis Pharmaceuticals Corp. has global marketing rights to Apligraf. | ||
| Line 42: | Line 42: | ||
[[Category:From CircLeaks]] | [[Category:From CircLeaks]] | ||
[[Category:From IntactWiki]] | [[Category:From IntactWiki]] | ||
| + | |||
| + | [[de:{{FULLPAGENAME}}]] | ||
Revision as of 18:18, 17 November 2019
Apligraf is a synthetic skin created from harvested foreskins.[1] It is FDA approved,[2] and it is made and sold by Organogenesis, which a corporation based in Canton, MA. Novartis Pharmaceuticals Corp. has global marketing rights to Apligraf.
Apligraph Oral
Organogenesis is presently seeking FDA approval for Apligraph Oral, a foreskin-derived product for the "treatment of surgically treated gingival and alveolar mucosal surface defects in adults."[3]
References
- ↑
Apligraf: How Is It Made?
, Organogenesis. Retrieved 6 March 2011.
Quote:Human keratinocytes and fibroblasts are derived from neonatal foreskins
- ↑
Apligraf
, Organogenesis. Retrieved 6 March 2011.
Quote:Apligraf® is the first bio-engineered cell based product to receive FDA approval (in 1998).
- ↑
(17 November 2011)."November 17, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting: Transcript", FDA. Retrieved 20 December 2011.
